Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergyMarta Muzio, Paolo Ghia, Federico Caligaris‐Cappio et al.|Blood|2008Cited by 228
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLLAlessandro Campanella, Paolo Ghia, A Capasso et al.|American Journal of Hematology|2024Cited by 15
P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLLAlessandro Campanella, Paolo Ghia, Antonella Capasso et al.|HemaSphere|2023Cited by 0